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Abstract: Food allergy (FA) has become an increasing problem throughout the world. Over the last 2 decades, the frequency of FA
has increased in both children and adults. The prevalence differs according to the research methodology, age, and geographic regions,
ranging between 2.0% and 10.0%. The most common form of FA is immunoglobulin E (IgE)-mediated FA. In this form, patients may
present with life-threatening conditions, such as anaphylaxis, or milder conditions, such as urticaria, angioedema, sneezing, and nausea
alone. The gold standard in the diagnosis of FA is oral provocation tests. Epidermal skin prick tests and specific IgE measurements, as
well as component-resolved diagnostic techniques are helpful in the diagnosis and follow-up of patients. In this review, the epidemiology,
diagnosis, follow-up, and prognosis of IgE-mediated FA in children and adults were discussed and some specific forms of FA, such as
pollen FA syndrome, alpha-gal allergy, and food-dependent exercise-induced anaphylaxis were explained.
Key words: Alpha-gal allergy, anaphylaxis, food allergy, food challenge, IgE, pollen food allergy, skin prick test

1. Introduction
Food allergy (FA) is defined as an adverse health effect
arising from a specific immune response that occurs
reproducibly on exposure to a given food [1]. It should
be differentiated from nonimmune-mediated adverse
food reactions, which include metabolic (e.g., lactose
intolerance), pharmacologic (e.g., caffeine) and toxic (e.g.,
food poisoning) events [2]. FA is classified according to
the type of immune response, as immunoglobulin E (IgE)mediated, non-IgE–mediated, or mixed. The underlying
mechanisms, clinical findings, diagnostic methods,
management, and prognosis are different for each type [3].
This review focused on IgE-mediated FA.
The pathophysiology of IgE-mediated FA is simplified
in Figure 1.
2. Epidemiology in food allergy
2.1. In children
The prevalence of FA varies between 2% and 10%, based on
variants such as age, and geographical or race differences,
and the description of the allergy, i.e. whether it was oral
food challenge (OFC)-proven or self-reported by the
patients [1]. In the study of Osborne et al. [4], 1-yearold infants were screened for sensitization to common
allergens (peanuts, raw egg whites, and sesame) and
sensitized infants underwent OFC. More than 10% of the

1-year-old infants were reported as allergic to at least one
of the common allergens. Their follow-up study evaluated
the same participants at the age of 4 years old, wherein they
reported a decrease in the prevalence of challenge-proven
FA as 3.8%, due to the high resolution rate of egg allergy
[5]. The study of Sasaki et al. [6] reported the prevalence of
clinically-defined and self-reported FA in early adolescence
(10 to 14 years old) as 4.5% and 5.5%, respectively. The
most common allergen was peanuts, followed by tree nuts.
In the study of Chen et al. [7], 12–36-month-old toddlers
were evaluated for FA and the prevalence was reported
as 2.5%, wherein the most prevalent allergens were eggs,
peanuts, cow’s milk, and fish. Another study from China
showed that the prevalence of challenge-proven FA in
0–12-month-old infants was 3.8%, wherein the most
common allergen was eggs (2.5%), followed by cow’s milk
(1.3%). On the other hand, the prevalence of FA was higher
when the studies included patients with self-reported FA,
rather than challenge-proven. Gupta et al. reported that
11.4% of parents considered that their children had FA.
As the parent-reported reaction history was not consistent
with IgE-mediated FA, they excluded 4% of the children.
The prevalence of FA in children was estimated as 7.6% in
the USA, and the most common allergens were peanuts,
milk, shellfish, and tree nuts [8]. A questionnaire-based
study determined that the cumulative prevalence of FA
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Figure 1. Simplified pathophysiology of IgE-mediated FA.

was 6.7% in France and cow’s milk, eggs, kiwi, and peanuts
were the major food allergens [9]. In Turkish children,
the foods that most commonly cause FA were reported as
eggs (57.8%), cow’s milk (55.9%), and hazelnuts (21.9%)
[10]. Kahveci et al. showed that egg whites, cow’s milk,
tree nuts, and sesame were the most prevalent allergenic
foods in eastern Mediterranean children aged 0–24
months [11]. Kaya et al. showed that the OFC-proven FA
prevalence in Turkish adolescents was 0.15% and the most
common food allergen was peanuts, followed by tree nuts
[12]. Similar prevalence was reported by Mustafayev et al.;
however, walnuts were reported as the most common food
causing allergic reaction [13]. Common allergens vary
in the different geographic areas, possibly as the result of
culinary differences.
2.2. In adults
As in all other types of allergies, the incidence of FA has
been increasing in both adults and children [14]. Allergy
to commonly consumed foods in adults may be due to the
persistence of childhood FA or it may be adult onset. The
prevalence of IgE-mediated FA in adults depends on the

methodology of the study, and whether the patients were
included based on self-report or if a diagnostic workup
was performed. Most of the FA prevalence studies have
relied on self-report, International Statistical Classification
of Diseases-coded1 reactions, or the demonstration of
allergen-specific IgE (sIgE), without the confirmation of
symptoms with specific provocation [15]. Based on those
reports, the prevalence of FA in the adult North American
population was reported as 6.6%–10% [15]. However, these
prevalence rates would be lower if specific provocation
tests had been performed. In a metaanalysis, it was shown
that there was up to a 15-fold difference between the selfreported and challenge-proven prevalence of FA, where
the discordance was attributed to probable non-IgE–
mediated mechanisms [16]. In another metaanalysis of the
European population, the overall pooled point prevalence
of symptoms with positive sIgE to at least 1 food was 2.7%,
with the rate being slightly higher among children than
in adults [17]. In a study of a population between 18 and
60 years of age, conducted between 1 January 2000 and
30 September 2012, an estimate of the frequency ranges

World Health Organization. International Statistical Classification of Diseases [online]. Website: https://www.who.int/classifications/classification-ofdiseases [accessed 8 Feb 2021].
1
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of FA in Europe by self-report, positive IgE, symptoms
with positive IgE, and food challenge comprised 3.5%–
19.6%, 2%–21.9%, 2.2%, and 0.1%–3.2%, respectively
[17]. The lifetime prevalence of FA in this age group was
9.5%–35% [17]. In a study of 774 patients with seasonal
allergic rhinitis in Turkey, the prevalence of FA was the
most common accompanying allergic disease (14%) [18].
In a large population-based study of 11,810 participants,
the life-time prevalence of self-reported FA/nonallergic
food hypersensitivity was reported as 9.5%; however, the
rate was 0.1% when double-blind, placebo-controlled
food challenge tests were performed [19]. As most studies
are based on questionnaire data, and the prevalence of
FA may be influenced by many variables, such as sex,
age, nationality, and food consumption habits, the true
prevalence of FA among adults is currently unknown.
3. Diagnosis of food allergy
The gold standard diagnostic tool for FA is double-blind
placebo-controlled OFCs (DBPCFC). Since OFC has a
systemic reaction risk that includes fatal anaphylaxis,
other complementary diagnostic approaches should be
performed before the challenge test. Detailed clinical
history, skin prick test (SPT), sIgE level, as well as
component-resolved diagnostic (CRD) tests could help to
define the risk of OFC [20]. Intradermal tests, atopy patch
tests, allergen-specific IgG4 measurement, kinesiology, hair
analysis, and electrodermal testing are not recommended
for the diagnosis of FA [21–23].
3.1. Medical history
Clinical history and physical examination are the first
and most important procedures for the diagnosis of
FA. Although there are no specific symptoms, atopic
dermatitis or clinical findings at the acute phase of the
reaction might be a clue for diagnosis [1,3]. The clinical
history should include suspected allergens, form of the
food (baked, extensively heated, or raw), amount of
the consumed food, time interval between ingestion
and the reaction, outcomes of previous exposure to the
same allergen before the reaction, recurrence of the IgEmediated reaction after ingestion of the same culprit
food, cofactors during the reaction (e.g., exercise, alcohol,
infection, and nonsteroidal antiinflammatory drugs),
treatment and the duration of the symptoms, and time
of the last reaction [1,21,24]. Cutaneous (urticaria or
angioedema), respiratory (rhinorrhea, sneezing, stridor,
cough, wheezing, or dyspnea), gastrointestinal (nausea,
vomiting, abdominal pain, or diarrhea) or cardiovascular
(hypotension or shock) system symptoms within 2 h
after ingestion of the culprit food, or recurrent symptoms
after further exposure to the culprit food are significant
clues for the diagnosis of FA [25]. Accompanying atopic
diseases, including atopic dermatitis, allergic rhinitis,

asthma, and eosinophilic gastrointestinal disease should
also be recorded [24]. Clinical history alone is inadequate
to establish a diagnosis of FA [26]. A diagnostic work-up
should include SPTs, sIgE, and CRD results.
3.2. Skin prick test
SPT is a widely used diagnostic tool for IgE-mediated
allergies because the procedure is easy to perform,
reproducible, inexpensive, time-effective and highly
sensitive. SPT detects allergen sIgE antibodies in vivo
[27]. Allergen extracts, negative (usually 0.9% NaCl) and
positive controls (histamine, 10mg/mL) are dropped to the
volar surface of the forearm or upper back of the patient,
separately, and they are imported into the skin layer via a
1-mm lancet or similar device. The wheal size is measured
after 10–15 min. If the wheal size is 3 mm or greater
than the negative control, the test result for that allergen
is considered positive, in other words, the patient is
sensitized to that allergen [24]. In contrast to a low-positive
predictive value, SPT has a high-negative predictive value.
Therefore, when the SPT result is negative, the diagnosis
of FA is unlikely [26]. H1 antihistamines, long-term or
high-dose systemic corticosteroids, and omalizumab
should be stopped 4–5 days, 1–3 weeks, and 6 weeks,
respectively, before performing the SPT to avoid falsenegative results. In addition to that, topical steroids and
calcineurin inhibitors could suppress the immediate skin
test response when applied to the SPT area [27]. Although
it is not standardized, the prick-to-prick test with fresh
food can be performed when the allergen extract for the
suspected food is unavailable or the SPT result using the
extract is inconsistent with the clinical history [24]. For
cow’s milk, eggs, and peanuts, the 95% positive predictive
SPT values of clinical reactivity are described (Table 1)
[28,29]. In addition, a larger wheal size is more likely to
be associated with clinical reactivity to the culprit food.

Table 1. The 95% positive predictive SPT and sIgE clinical
reactivity values of different foods described for children [22–24].
95% PPV

Allergen

Age group

Cow’s milk

All ages
≤1 year
≤2 years
≤4 years
≤6 years

≥15
≥5
≥11.1
≥11.7
≥13.7

Eggs

All ages
≤2 years

≥7
≥2

≥7
≥5

≥15

≥8

Peanuts

sIgE kU/L

SPT (mm)
≥8
≥6
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However, the wheal size does not indicate the severity of
the reaction [30,31]. There is no international consensus
on the 95% positive predictive SPT values for other foods,
such as wheat, tree nuts, and fish [32].
3.3. Allergen-specific IgE levels
Like SPT, positive sIgE measurement results indicate
sensitivity to the culprit allergen, and results should be
carefully interpreted [24]. Different test methods have
been used to measure the sIgE level, each of which has
advantages and disadvantages. The common feature of
these systems is the in vitro determination of the allergen
sIgE antibody and the results are reported in kilo units per
liter (kU/L). Follow-up of sIgE levels should be checked
using the same method, as the measurement differences
might alter the accuracy of the results [27]. Similar to the
SPT, the 95% positive predictive values of sIgE for cow’s
milk, eggs, and peanuts were reported, and a high level
of sIgE is a significant predictor of clinical reactivity. The
predictive value of the sIgE level is affected the age of the
patient (Table 1) [28–30].
3.4. Role of component-resolved diagnosis
In CRD tests, allergen specific food antigens and epitopes
are detected using qualitative, semiquantitative, or
quantitative assays. Therefore, high levels of sIgE due to
cross-reactive components of other food antigens could be
distinguished from allergenic ones [27]. Cow’s milk, eggs,
peanuts, and tree nuts have well-defined components,
where if positive, indicate increased likelihood of
reactivity. Patients who have high levels of casein (Bos d8)
and ovomucoid (Gal d1) cannot tolerate extensively heated
(baked) cow’s milk and eggs, respectively. In addition,
increased levels of casein and ovomucoid sIgE indicate the
persistence of the FA [33,34]. Ara h 2 for peanuts, Gly m 8
for soybeans, Ana o 3 for cashews, Jug r 1 for walnuts, Cor
a 9 and 14 for hazelnuts, Ses I 1 for sesame, and Fag e 3 for
buckwheat have been associated with clinical FA [35–42].

Unlike SPT and sIgE results, CRD tests can predict the
severity of the reaction. Ara h 2 and 6 for peanuts, and Cor
a 9 and 14 for hazelnuts have been reported as risk factors
for severe allergic reactions [43,44]. The cross-reactive
components of the food allergens are described in Table
2. Although CRD tests are widely used, the diagnostic
accuracy, cut-off values, and cost-effectiveness for FA are
problems that should be addressed.
3.5. Oral food challenges
OFC is the only procedure that could establish the diagnosis
of FA. Since DBPCFC, which is the gold standard method
for diagnosis, is a time-consuming procedure and requires
a standard method of food processing, patients frequently
undergo open or single-blind food challenges. DBPCFC
should be performed in patients who have defined
subjective and psychological symptoms in order to avoid
false positive results and unnecessary food restriction [25].
In addition, OFCs for research settings should be performed
with double-blind procedures [45]. OFC with suspicion of
IgE-mediated allergy must be performed in an office or
hospital setting, where the personnel and equipment are
adequate to treat a severe allergic reaction [20]. Similar
to SPT, certain medications (H1- and H2-antihistamines,
atypical antidepressants/sedatives, benzodiazepines,
and tricyclic antidepressants), which have a suppressant
effect on the test results, should be discontinued before
the procedure. The interval between the last dose of the
drug and the challenge test depends on the half-life of the
medication. In addition, the patient should discontinue
their medications, including ACE inhibitors, betablockers, cromolyn, nonsteroidal antiinflammatory drugs,
proton pump inhibitors, short, medium, and long-acting
bronchodilators, oral bronchodilators, 5 half-lives before
the OFC to avoid severe reactions [45]. In Japanese FA
guidelines, low, medium, and full dose food challenge
procedures were described. It was proposed that the

Table 2. Major allergen components involved in cross-reactivity between pollen and food allergens.
Allergen family

Allergen components involved in cross-reactivity

LTP (heat and digestion stable)

Ar v 3 (mugwort), Pla a 3 (London plane tree), Amb a 6 (short ragweed)
Pru p 3(peach), Mal d 3 (apple), Api g 2 (celery), Sin a 3 (yellow mustard)

2S albumins

No aeroallergens
Ana o 3 (cashew), Ara h 2 (peanut), Pis v 1 (pistachio), Gly m 8 (soybean)

Cupin

No aeroallergens
Prudu 6 (almond), Cor a 9 (hazelnut), Pis v 2 (pistachio), Ara h 1 (peanut)

PR-10 (denature with cooking/processing)

Bet v1 (birch), Que a 1 (White oak), Aln g 1 (alder), Fag s 1 (beech)
Mal d 1 (apple), Pruar 1 (apricot), Api g 1 (celery), Ara h 8 (peanut)

Profilin (denature with digestion)

Bet v 2 (birch), Art v 4 (mugwort), Amba 8 (ragweed), Phl p 12 (Timothy grass)
Mal d 4 (apple), Api g 4 (celery), Pru p 4 (peach), Ara h 5 (peanut)
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decision for a challenge dose should be made according
to the risk analysis of the patient, including their clinical
history, SPT, sIgE, and CRD results. Although, a highdose challenge should be performed for FA labeling [46],
in the consensus report of Ebisawa et al., at least 2 g of
food protein was suggested as the top dose to prevent
false negative results. The general challenge schedule
consists of half-logarithmic dose increments, from 3 mg
to 3 g of food protein, in order to avoid severe reactions.
Dose intervals should be at least 20 min. The challenge
test should be stopped when the patient has any objective
symptoms and proper treatment should be provided [20].
If the patient describes subjective symptoms, the challenge
may continue until objective symptoms occur or the dose
interval can be extended, the dose in the previous step can
be repeated, or the test can be repeated as DBPCFC [47].
4. Prognosis of food allergy in children
Children who have cow’s milk, eggs, soy, and wheat
allergies could tolerate the allergen at a rate resolution
range of 52%–79%, 49%–68%, 69%, and 65%, respectively.
In contrast to these allergens, peanuts, tree nuts, and fish
allergies remain throughout the life span of an individual
in most cases [1]. Sicherer et al. reported that 49.3% of
children who have an egg allergy could tolerate eggs at a
median age of 72 months [48]. Savage et al. predicted a
68% resolution rate of egg allergy at the age of 16 years
[49]. Similar to eggs, allergy to cow’s milk may resolve in
52.6% of patients at a median age of 63 months, and 79%
of patients could be tolerant by the age of 16 years [50,51].
Keet et al. showed that the median age of tolerance to
wheat allergy was approximately 78 months and the rate
of resolution was 65% by 12 years of age [52]. The study
of Peters et al. [53] demonstrated that peanut allergy
resolved in 22% of patients by the age of 4 years. The rate
of resolution of tree nut allergy was reported as 10% in
3–21-year-old patients [54].
5. Treatment of food allergy
To date, no curative treatment option has been reported
for FA [1]. Acute treatment includes the management of
allergic reactions and anaphylaxis [55]. Elimination diets,
education on allergen labeling, cross-contamination,
and scheduled clinical follow-up are the main tools of
management [56]. Strict avoidance of the culprit food might
cause nutritional deficits. Therefore, dietary consultation
should be performed, especially if the patient has multiple
FAs and nutritional support should be considered in order
to avoid nutritional deficiency [25].
Three decades ago, allergen-specific immunotherapy
for FA was described. Several studies about the efficacy

of oral, epicutaneous, and sublingual immunotherapies
for peanuts, eggs, cow’s milk, and hazelnuts were
reported [57–60]. The main aim of immunotherapy is to
provide desensitization or sustained unresponsiveness
to the offending allergen. Desensitization could be
accomplished after months of therapy, which provides
tolerance to the allergen during the treatment phase. After
cessation of immunotherapy, most desensitized patients
could not tolerate the allergen. However, in sustained
unresponsiveness, patients could ingest the allergenic
food with no clinical reaction for several months after the
end of the therapy. This could be achieved only in some
patients who received immunotherapy for years [56].
In oral immunotherapy (OIT), an allergen powder is
ingested daily at increasing doses (initial dose escalation
and dose build-up, from micrograms to 300–4000 mg
protein/ day) until the maintenance phase. The initial
and build-up dose escalation phases should be performed
under the supervision of a physician. Maintenance doses
could be self-ingested at home. This phase may take
months or years [61]. OIT has higher desensitization
and sustained unresponsiveness ratio than those of
other immunotherapy modalities. However, OIT has the
risk of serious adverse events, which include systemic
reactions and the development of eosinophilic esophagitis.
Gastrointestinal side-effects have been reported as the
most common dose-limiting adverse reactions [62,63].
Omalizumab, a monoclonal anti-IgE antibody, can be
administered during the escalation phase in order to
decrease the severity of IgE-mediated adverse events [64].
More recently, the FDA approved the first drug for peanut
OIT.2
In sublingual and epicutaneous immunotherapy,
allergen extract drops and patches are applied, respectively,
at lower doses than OIT. Compared to OIT, those methods
are safer; however, the rates of desensitization and
sustained unresponsiveness are lower than those of OIT
[56].
A practical approach to diagnosis and follow-up of
IgE-mediated FA is presented in Figure 2.
6. Prevention of food allergy in high-risk children
The study of Du Toit et al. [65] was the most informative
research to understand the prevention approach for FA.
High-risk infants (4–11 months old) with FA, who had
severe eczema, egg allergy, or both, were included in the
study. Patients were randomized into 2 groups, as the
avoidance group and consumption group. The infants
in the avoidance group avoided peanuts until the age of
5 years old, whereas infants in the consumption group
started consuming peanuts at around 6 months of age.

U.S. Food & Drug Administration (2020). FDA approves first drug for treatment of peanut allergy for children [online]. Website: https://www.fda.gov/
news-events/press-announcements/fda-approves-first-drug-treatment-peanut-allergy-children [accessed 22 March 2020].
2
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Figure 2. Practical approach to the diagnosis and follow-up of FA.

At the age of 60 months, the prevalence of peanut allergy
was reported as 13.7% and 1.9% in the avoidance and
consumption groups (P = 0.004), respectively. According
to their study, the early introduction of peanuts to highrisk infants was suggested to prevent peanut allergy. In
contrast, studies that have investigated the effects of early
egg exposure in infants have reported inconsistent results
for the prevention of egg allergy [21]. Oniwaza et al. [66]
reported that delayed introduction to cow’s milk could be
associated with IgE-mediated cow’s milk allergy. Urashima
et al. [67] demonstrated that avoiding cow’s milk formula
for at least first 3 days of life could prevent sensitization to
cow’s milk. In addition, the restriction of allergenic foods
during pregnancy or breast-feeding was not recommended
to prevent FA [68].
7. Adult onset allergy to common foods
Cow’s milk allergy that persists into adulthood is
uncommon, and most children with egg allergies also
develop tolerance as they grow older [69]. On the other
hand, the majority of peanut allergic adults acquire it in
the childhood [69]. Adult-onset milk, egg, and peanut
allergy may be rarely observed.
The underlying mechanism of FA in adults is primary
sensitization to a nonfood allergen that has antigenic
similarity to food, and is a cross-reactive type that results in
the loss of tolerance to previously consumed foods (class 2
FA) [70]. Although less common, sensitization may occur
directly to the food allergen (class 1 FA). IgE-mediated
FA in adults may present with anaphylaxis, pollen FA
syndrome (PFAS), oral allergy syndrome (OAS), alpha-gal
allergy, or food-dependent exercise-induced anaphylaxis
(FDEIA) [70].
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Seafood allergy is one of the most common types of adult
FA. Sensitization occurs upon consumption, skin contact,
or inhalation of aerosolized allergens while cooking or
food processing [71]. Tropomyosin and arginine kinase
are the allergens responsible for cross-reactivity of shellfish
with parasites, mites, and insects. However, componentresolved diagnosis will allow the identification of shellfishspecific allergens in the near future [71]. Parvalbumin is
the major fish allergen that varies among species. Herring,
codfish, salmon, and pollock were reported to be the most
allergenic and cross-reacting, whereas mackerel, tuna,
and halibut were reported as the least allergenic species
[72]. Anisakis is a parasite that may contaminate fish, and
cause allergic sensitization and the misdiagnosis of fish
allergy. Scombroid poisoning is another type of reaction
that mimics an allergic reaction, which results from the
ingestion of improperly processed or stored fish that
contain a high level of histamine. Although the reaction is
clinically typical for IgE-mediated type allergens, it is nonIgE–mediated and is not reproducible.
8. Evaluation and management of food allergy in adults
After consumption of the offending food, the typical
symptoms of IgE-mediated FA usually develop in 1 to 2
h. The symptoms range from mild urticaria/angioedema
and gastrointestinal symptoms to severe anaphylaxis, and
even death. The diagnosis of FA in adults should involve
a stepwise approach. A detailed history of the reaction,
and a list of all of the possible allergens ingested at least
6 to 8 h prior to reaction should be documented. A food
that cross-reacts with an inhalant allergen (latex, pollen,
or house dust mites) may be responsible for the current
sensitization. Reaction history upon ingestion of cross-
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reacting foods with those inhalant allergens should be
questioned.
Diagnosis and treatment are similar to childhood cases;
however, most of the food allergies in the adult population
persist throughout life.
9. Pollen food allergy syndrome
Instead of the commonly used term OAS, the term PFAS has
better characterized the pathogenesis since its introduction
in 1995 [73]. PFAS is defined as the development of allergic
symptoms after the ingestion of fruits or vegetables in
patients with pollen allergy-associated rhino conjunctivitis.
Due to wide geographic variability, the true prevalence of
the syndrome is difficult to determine. However, as 47%–
70% of patients allergic to pollen have PFAS, the prevalence
should range between 9.4% and 35% in the general
population [73].
Plant food allergens belong to 3 protein superfamily
classes, namely prolamin, cupin and pathogenesis-related
(PR) proteins. Lipid transfer proteins (LTPs) belong to a
prolamin superfamily that are both heat- and digestionresistant (e.g., Mal d 3 and Pru p 3), and are found in many
vegetables and fruits as pan-allergens [73]. The 2S albumins
are also members of prolamin superfamily; however, their
role in PFAS is limited. There is no described 2S albumin
aeroallergen, so any identified 2S albumin allergen (e.g.,
Ana o 3 and Ara h 2) is a food allergen with sensitization
that occurred through the gastrointestinal tract (class 1
FA), not as a cross-reactivity. Similar to 2S albumin, no
cross-reacting aeroallergens have been found in the cupin
superfamily (class 1 FA), and seed storage proteins (7S and
11S) are mostly related to allergy in the cupin superfamily
of proteins [73]. PR-10 proteins are the most studied of the
PR family. These proteins often denature with processing
or cooking. Profilin family proteins are easily degraded
in the stomach; therefore, systemic symptoms beyond
oral symptoms are rare. However, due to the extensive
homology among themselves, profilin sensitization occurs
with multiple pollen-associated FA [73]. Table 1 shows the
protein components of foods and pollens.
The most common cross-reacting foods to profilins
are melon, watermelon, tomato, banana, and citrus. The
reactions are usually mild; nevertheless, more severe
reactions have been reported as the result of cosensitization
to LTPs and profilins [74]. PR-10 protein and Bet v 1 are
responsible for the symptoms of individuals with birch pollen
allergy upon the ingestion of apples, hazelnuts, carrots, and
celery. LTPs are abundant, especially in the peels of Rosaceae
fruit (pears and apples), and apricots, peaches, cherries, and
plums. In the case of LTP sensitization, there is an increased
risk of more severe reactions, and LTPs may cause FA in the
absence of pollen allergy [74]. The severity of the reaction
depends on the sensitization pattern, and whether it is to a
stable (LTP) or labile (PR-10, profilin) protein.

Most patients with PFAS initially exhibit oral
symptoms, such as lip and mouth itching and/or
angioedema with allergen exposure that will progress to
systemic symptoms and even anaphylaxis with further
exposure to the offending food. The misclassification of
those patients as having simple oral allergy may lead to
underdiagnosis and undertreatment [75]. Symptoms
restricted to the oral cavity and lips are usually self-limited
and do not progress with time; however, in a small number
of patients, this reaction may progress to a more serious
systemic type [75].
PFAS management includes the avoidance of the
offending foods and provision of well-cooked or canned
foods to patients. If there is uncertainty about the
tolerance to known cross-reacting foods, challenge tests
should be performed. The decision on the prescription
of an adrenaline autoinjector should be carefully made
considering the risk of systemic reaction and LTP
sensitization. Patients with any form of systemic reaction
should be prescribed an adrenaline autoinjector as a
precaution [74].
10. Alpha-gal allergy
There are 3 distinct forms of red meat allergy, which are
primary, pork-cat syndrome, and alpha-gal syndrome [76].
Primary beef allergy typically presents in childhood, porkcat syndrome is most common in adolescents, whereas
alpha-gal syndrome may present at any age [76].
Galactose- alpha-1,3-galactose (alpha-gal) is a newly
identified food allergen. Reactions to this allergen occur in
2 forms, comprising delayed reactions after the ingestion
of beef, pork, or lamb products, and immediate reactions
after cetuximab exposure [77].
In 2009, it was shown in a group of patients that
after eating mammalian meat, they experienced delayed
anaphylaxis or urticaria/angioedema with a lack of
immediate oral symptoms, and demonstrated IgE
antibodies to alpha-gal [78]. There are alpha-gal epitopes
within the saliva of ticks, and it is certain that sensitization
to alpha-gal is related to the bites of hard ticks [76].
Contrary to other types of FA, even with high titers of
sIgE to alpha-gal, the earliest symptom onset is 150 min
(120 to 750 min) on average [76]. This raises the suspicion
on the non-IgE mechanism; however, all evidence supports
the fact that alpha-gal syndrome is an IgE-mediated
disease.
A study including 261 patients allergic to meat (35
children, 226 adults), admitted to the University of Virginia
Allergy Clinic, reported that the serum sIgE to alpha-gal
was >0.35 IU/mL in 94% of the individuals, and when
compared to the adults, there was male preponderance
among the children (74% vs. 42% males), and the meat
allergy was due to alpha-gal syndrome in 95% of these
patients. It was observed that the presence of blood group
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B was protective against the development of the syndrome,
and the syndrome was not associated with other atopic
diseases [79].
Alpha-gal hypersensitivity is not only associated with
food-related symptoms, but also other exposure, including
gelatin or porcine/bovine-containing bioprosthetic heart
valves, medications (e.g., heparin), and vaccines, can
elucidate symptoms [80]. However, the amount of alphagal that is present in certain medications and their safety
in patients with alpha-gal syndrome is currently unknown
[81].
The management of alpha-gal syndrome includes
dietary counseling for avoidance and a prescription for an
adrenalin autoinjector. The titers of sIgEto alpha-gal may
decrease over time, and the reintroduction of red meat
into the diet may be possible when proof of tolerance has
been established over several years [76].
11. Food-dependent exercise-induced anaphylaxis
Exercise-induced anaphylaxis can occur in 2 forms:
anaphylaxis caused exclusively by exercise and that
which occurs after eating and exercising, i.e. FDEIA. If
anaphylaxis occurs after ingestion of a certain food that
the patient is sensitized to, this is known as specific FDEIA,
while if anaphylaxis occurs with any type of food, then
it is called nonspecific FDEIA [82]. The true prevalence
is unknown because in most cases, the sensitized food
cannot be identified and patients are categorized as
idiopathic anaphylaxis, or there is a lack of awareness
among physicians.
The underlying mechanism of FDEIA is IgE-mediated
FA that is aggravated by cofactors, such as exercise,
nonsteroid antiinflammatory drugs, or alcohol. The
symptoms, which may begin at any stage of exercise
or just after exercise, may be aggravated with another
cofactor, and may be unpredictable [82]. The responsible
food is usually ingested within 4 h preceding exercise or
after exercise [83]. Reaction starts as a sudden feeling of
fatigue, flushing, and pruritus w/wo urticaria. Maintaining
exercise may lead to severe anaphylaxis with hypotension
and collapse. On the other hand, if patients stop exercising,
the symptoms usually resolve [82].
Depending on the region and dietary habits, culprit
foods may change and almost any food or combination
of food allergens can cause FDEIA. Diagnosis is not easy,
and requires a detailed clinical history and a high level of
suspicion. The suggested criteria for diagnosis are [83]:
· Diagnosis of anaphylaxis during (within 1 h) exercise
that occurs only if preceded by food ingestion.
· No other situation that can explain the clinical
presentation.
In the case of the presence of a specific food trigger:
· The demonstration of sIgE to that food, either by skin
or serum testing
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· Patients usually consume the specific food safely
without exercise, or safely exercise without consuming the
specific food (in the absence of cofactors).
Skin testing, and/or in vitro sIgE testing, and if
inconclusive, skin testing with fresh food is performed
to show sensitization. A positive food + exercise testing
confirms FDEIA diagnosis; however, a negative test does
not always exclude diagnosis [83]. The identification and
avoidance of contributing factors and foods is vital. Patients
should carry adrenaline autoinjectors, stop exercise
immediately if any symptoms occur, avoid the culprit food
4–6 h (at least 2 h) before exercise, not exercise alone, and
preferably, exercise with an informed individual [83].
12. Future perspectives
The true prevalence of FA, especially among the adult
population, is currently unknown, as self-reported
and proven FA rates significantly differ. Specific IgE
measurement has low specificity and may increase the
overdiagnosis rates, and in most cases, food challenge
is not performed. Highly cross-reactive carbohydrate
epitopes and cross-contamination with other allergens
contribute to lower specificity of the allergen extracts, both
for SPT and sIgE measurement.
Many proteins can be probed simultaneously and
epitope pattern analysis can be performed with microarraybased assays using very small amounts of patient serum.
However, more studies on the clinical application of the
method should be performed.
The basophil activation test (BAT), with a specific
antigen, has shown that the biologic response and specificity
of the test is probably higher than an sIgE measurement.
However, the method is not widely available, as fresh
serum is needed, and more clinical research investigating
the role of BAT in FA should be conducted.
Greater microbial diversity in the gut may favor
tolerance induction to foods. Mouse studies have shown
that therapy with protective clostridial species has
suppressed FA, and gut microbiota dysbiosis would be a
potential future target for therapy [84]. However, welldesigned prospective studies on humans are needed to
understand if microbial changes or dysbiosis in the gut
predispose an individual to the development of FA, and
if so, what strategies could be used to induce tolerance.
For FA prevention and treatment, diet manipulation, proand presynbiotic supplementation, and fecal microbiota
transfer may be potential future research topics.
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